Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol

<table>Specific IgE during the incremental and maintenance phases in group A (□) (Vespidae 18; Apidae: 9; <svg height="11.125" id="M21" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 44.400002 11.125" width="44.400002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45B"></use></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><use xlink:href="#x3D"></use></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><use xlink:href="#x32"></use></g><g transform="matrix(.017,-0,0,-.017,36.168,10.862)"><use xlink:href="#x37"></use></g>
</svg>), group B (▪) (Vespidae 16; Apidae 9 <svg height="11.125" id="M22" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 44.400002 11.125" width="44.400002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45B"></use></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><use xlink:href="#x3D"></use></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><use xlink:href="#x32"></use></g><g transform="matrix(.017,-0,0,-.017,36.168,10.862)"><use xlink:href="#x35"></use></g>
</svg>), and group C (▪) (Vespidae 16; Apidae 8; <svg height="11.125" id="M23" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 44.400002 11.125" width="44.400002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x1D45B"></use></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><use xlink:href="#x3D"></use></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><use xlink:href="#x32"></use></g><g transform="matrix(.017,-0,0,-.017,36.168,10.862)"><use xlink:href="#x34"></use></g>
</svg>). Bars indicate the mean ± SEM.</table>

Journal of Allergy

fig4

Figure 4

Figure 4: Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol 